Abstract
X-ray crystallographic fragment screening (XCFS) uses fragment-sized molecules (∼60 to 300 Da) to access binding sites on proteins that may be inaccessible to larger drug-like molecules (>300 Da). Previous studies have shown that fragments containing halogen atoms bind more often to proteins than non-halogenated fragments. Here, we designed the Halo Library containing 46 halogenated fragments (including the “universal fragment” 4-bromopyrazole), a majority of which have been reported to bind to or inhibit one or more targets. The library was screened against the crystals of HIV-1 reverse transcriptase with the drug rilpivirine, yielding an overall hit rate of 26%. Two new binding sites were discovered, and several hot spots were identified. This small library may thus provide a convenient tool for rapidly assessing the feasibility of a target for XCFS, mapping hot spots and cryptic sites, as well as finding fragment binders that can be useful for developing drug leads.
Original language | English (US) |
---|---|
Pages (from-to) | 6013-6024 |
Number of pages | 12 |
Journal | Journal of medicinal chemistry |
Volume | 66 |
Issue number | 9 |
DOIs | |
State | Published - May 11 2023 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Drug Discovery